Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II

In the phase III ASCLEPIOS I and II trials, participants with relapsing multiple sclerosis receiving ofatumumab had significantly better clinical and magnetic resonance imaging (MRI) outcomes than those receiving teriflunomide. To assess the efficacy and safety of ofatumumab versus teriflunomide in...

Full description

Bibliographic Details

Published in:	Multiple sclerosis Vol. 28; no. 10; p. 13524585221078825
Main Authors:	Gärtner, Jutta, Hauser, Stephen L, Bar-Or, Amit, Montalban, Xavier, Cohen, Jeffrey A, Cross, Anne H, Deiva, Kumaran, Ganjgahi, Habib, Häring, Dieter A, Li, Bingbing, Pingili, Ratnakar, Ramanathan, Krishnan, Su, Wendy, Willi, Roman, Kieseier, Bernd, Kappos, Ludwig
Format:	Journal Article
Language:	English
Published:	England 01.09.2022
Subjects:	Relapsing multiple sclerosis treatment-naive neurofilament light chain no evidence of disease activity progression independent of relapse activity recently diagnosed
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!